Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite.
暂无分享,去创建一个
J. Baird | J. Carlton | M. Galinski | H. D. del Portillo | P. Alonso | I. Mueller | Hernando A del Portillo | Jane M Carlton | Ivo Mueller | Pedro L Alonso | D. Kochar | Mary R Galinski | J Kevin Baird | J. Baird | Dhanpat K Kochar
[1] J. Coura,et al. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection--a review. , 2006, Memorias do Instituto Oswaldo Cruz.
[2] J. Baird. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. , 1995, Parasitology today.
[3] C. Chitnis,et al. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion , 1994, The Journal of experimental medicine.
[4] W. A. Krotoski. Discovery of the hypnozoite and a new theory of malarial relapse. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] Simon I Hay,et al. Mapping the global extent of malaria in 2005. , 2006, Trends in parasitology.
[6] J. Baird. Neglect of Plasmodium vivax malaria. , 2007, Trends in parasitology.
[7] R. Sinden,et al. Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. , 1986, The American journal of tropical medicine and hygiene.
[8] J. Baird,et al. Can primaquine therapy for vivax malaria be improved? , 2003, Trends in parasitology.
[9] J. Sattabongkot,et al. A Novel Chimeric Plasmodium vivax Circumsporozoite Protein Induces Biologically Functional Antibodies That Recognize both VK210 and VK247 Sporozoites , 2006, Infection and Immunity.
[10] J. Carlton,et al. Comparative evolutionary genomics of human malaria parasites. , 2008, Trends in parasitology.
[11] M. Dietrich,et al. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria , 2006, Tropical medicine & international health : TM & IH.
[12] Jianbing Mu,et al. Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein. , 2005, The American journal of tropical medicine and hygiene.
[13] C. Newbold,et al. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[14] L. Miller,et al. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Barnwell,et al. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax , 1989, The Journal of experimental medicine.
[16] A. Das,et al. Plasmodium vivax Malaria , 2005, Emerging infectious diseases.
[17] W. Alecrim,et al. Chloroquine-Resistant Plasmodium vivax, Brazilian Amazon , 2007, Emerging infectious diseases.
[18] M. Galinski,et al. Plasmodium vivax: who cares? , 2008, Malaria Journal.
[19] K. Mendis,et al. Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types , 1987, The Journal of experimental medicine.
[20] S. Herrera,et al. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. , 2002, International journal for parasitology.
[21] M. Ciucă,et al. Immunity in malaria , 1934 .
[22] Rogerio Amino,et al. Manipulation of Host Hepatocytes by the Malaria Parasite for Delivery into Liver Sinusoids , 2006, Science.
[23] H. D. del Portillo,et al. Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker. , 1998, The Journal of infectious diseases.
[24] L. Rivière,et al. Antigenic variation in Plasmodium falciparum. , 2008, Annual review of microbiology.
[25] R. Price,et al. Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia , 2008, PLoS medicine.
[26] S. Kitchen,et al. The Infection of Reticulocytes by Plasmodium Vivax 1 , 1938 .
[27] K. Kain,et al. Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. , 1996, The Journal of infectious diseases.
[28] M. Galinski,et al. Plasmodium vivax: malarial proteins associated with the membrane-bound caveola-vesicle complexes and cytoplasmic cleft structures of infected erythrocytes. , 1990, Experimental parasitology.
[29] M. Khatri,et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. , 2009, The American journal of tropical medicine and hygiene.
[30] R. Rosenberg. Plasmodium vivax in Africa: hidden in plain sight? , 2007, Trends in parasitology.
[31] R. Rosenberg,et al. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Price,et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. , 2007, The Journal of infectious diseases.
[33] J. Sattabongkot,et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. , 2006, The American journal of tropical medicine and hygiene.
[34] X. Su,et al. Local Adaptation and Vector-Mediated Population Structure in Plasmodium vivax Malaria , 2008, Molecular biology and evolution.
[35] W. Perea,et al. Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[36] K. Mendis,et al. The neglected burden of Plasmodium vivax malaria. , 2001, The American journal of tropical medicine and hygiene.
[37] E. Legrand,et al. Plasmodium falciparum malaria in splenectomized patients: two case reports in French Guiana and a literature review. , 2004, The American journal of tropical medicine and hygiene.
[38] I. Sherman. Molecular approaches to malaria , 2005 .
[39] D. J. Kim,et al. Clinical Features of Plasmodium Vivax Malaria , 2003, The Korean journal of internal medicine.
[40] G. Snounou,et al. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. , 2004, Trends in parasitology.
[41] M. Fay,et al. Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 , 2008, PloS one.
[42] J. Baird,et al. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] J. Barnwell,et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. , 2006, The American journal of tropical medicine and hygiene.
[44] C. Chitnis,et al. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys. , 2005, The American journal of tropical medicine and hygiene.
[45] J. Sachs,et al. A global index representing the stability of malaria transmission. , 2004, The American journal of tropical medicine and hygiene.
[46] M. Galinski,et al. Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques. , 2008, Vaccine.
[47] F. McKenzie,et al. GAMETOCYTEMIA AND FEVER IN HUMAN MALARIA INFECTIONS , 2007, The Journal of parasitology.
[48] A. Tatem,et al. The Limits and Intensity of Plasmodium falciparum Transmission : Implications for Malaria Control and Elimination Worldwide , 2007 .
[49] J. Baird,et al. Chloroquine Resistance in Plasmodium vivax , 2004, Antimicrobial Agents and Chemotherapy.
[50] Andrew J Tatem,et al. The global distribution and population at risk of malaria: past, present, and future. , 2004, The Lancet. Infectious diseases.
[51] M. Galinski,et al. 8 A Mechanistic Approach to Merozoite Invasion of Red Blood Cells: Merozoite Biogenesis, Rupture, and Invasion of Erythrocytes , 2005 .
[52] C. Bonini-Domingos,et al. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[53] H. D. del Portillo,et al. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria , 2009, Malaria Journal.
[54] Nicholas J White,et al. Vivax malaria: neglected and not benign. , 2007, The American journal of tropical medicine and hygiene.
[55] W. Collins,et al. Plasmodium vivax: in vitro growth and reinvasion in red blood cells of Aotus nancymai. , 1988, Experimental parasitology.
[56] J. Sattabongkot,et al. Cultivation of Plasmodium vivax. , 2008, Trends in parasitology.
[57] Kamolrat Silamut,et al. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. , 2004, The Journal of infectious diseases.
[58] P. Borst,et al. Antigenic variation in African trypanosomes. , 1994, Science.
[59] Bart Barrell,et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax , 2001, Nature.
[60] M. Chen-Mok,et al. Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. , 2005, The American journal of tropical medicine and hygiene.
[61] M. Cetron,et al. Delayed onset of malaria--implications for chemoprophylaxis in travelers. , 2003, The New England journal of medicine.
[62] M. Gatton,et al. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. , 2007, The Journal of infectious diseases.
[63] S. Kitchen,et al. On the Infectiousness of Patients infected with Plasmodium vivax and Plasmodium falciparum. , 1937 .
[64] Michael Lanzer,et al. Variant genes and the spleen in Plasmodium vivax malaria. , 2004, International journal for parasitology.
[65] P. Siba,et al. Pharmacokinetics and Efficacy of Piperaquine and Chloroquine in Melanesian Children with Uncomplicated Malaria , 2007, Antimicrobial Agents and Chemotherapy.
[66] S. Herrera,et al. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. , 2005, The American journal of tropical medicine and hygiene.
[67] Virander S. Chauhan,et al. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. , 2007, Vaccine.
[68] Bruce Russell,et al. The pathophysiology of vivax malaria. , 2009, Trends in parasitology.
[69] J. Carlton,et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. , 2007, The Journal of infectious diseases.
[70] P. Newton,et al. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. , 2007, International journal for parasitology.
[71] C. Chitnis,et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection , 2008, Proceedings of the National Academy of Sciences.
[72] I. Elyazar,et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. , 2007, The American journal of tropical medicine and hygiene.
[73] Mary R. Galinski,et al. A reticulocyte-binding protein complex of plasmodium vivax merozoites , 1992, Cell.
[74] Hagai Ginsburg,et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites , 2008, Proceedings of the National Academy of Sciences.
[75] I. Mueller,et al. The risk of malarial infections and disease in Papua New Guinean children. , 2007, The American journal of tropical medicine and hygiene.
[76] Jonathan Crabtree,et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax , 2008, Nature.
[77] K. Mendis,et al. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[78] H. D. del Portillo,et al. A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1 , 2006, Infection and Immunity.
[79] Elissa M. Malkin,et al. Progress towards the development of malaria vaccines. , 2006, Trends in parasitology.
[80] S. Hoffman,et al. Primaquine therapy for malaria. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] R. Price,et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison , 2007, The Lancet.
[82] Irwin W. Sherman,et al. Malaria : parasite biology, pathogenesis, and protection , 1998 .
[83] D. Hartl,et al. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. , 2008, Gene.
[84] H. Webster,et al. The epidemiology of malaria in a Karen population on the western border of Thailand. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[85] H. D. del Portillo,et al. Variant proteins of Plasmodium vivax are not clonally expressed in natural infections , 2005, Molecular microbiology.
[86] Suradi,et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. , 1997, The American journal of tropical medicine and hygiene.
[87] S. Herrera,et al. An update on the search for a Plasmodium vivax vaccine. , 2007, Trends in parasitology.
[88] S. Hoffman,et al. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[89] W. Collins,et al. Primate malarias. , 1974, Advances in veterinary science and comparative medicine.
[90] J. Barnwell,et al. Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria , 1983, Infection and immunity.
[91] P. Garnham,et al. Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. 1948. , 2000, Bulletin of the World Health Organization.
[92] R. Snow,et al. The consequences of reducing transmission of Plasmodium falciparum in Africa. , 2002, Advances in parasitology.
[93] M. Galinski,et al. Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1. , 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[94] Shelby L. Bidwell,et al. Immune responses to Plasmodium vivax pre‐erythrocytic stage antigens in naturally exposed Duffy‐negative humans: a potential model for identification of liver‐stage antigens , 2005, European journal of immunology.
[95] C. Newbold,et al. Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi– a rodent malaria model , 1990, Parasite immunology.
[96] L. Miller,et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.
[97] I. Cattadori,et al. Spatiotemporal patterns of malaria incidence in northern Thailand. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[98] H. D. del Portillo,et al. Plasmodium vivax and the importance of the subtelomeric multigene vir superfamily. , 2009, Trends in parasitology.
[99] H. Dagoro,et al. Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes? , 2006, Malaria Journal.
[100] M. Alpers,et al. Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea , 2008, PLoS medicine.
[101] Karsten M. Borgwardt,et al. The genome of the simian and human malaria parasite Plasmodium knowlesi , 2008, Nature.